Keratometers Market Regional Analysis

Global Keratometers Market size was valued at USD 313.2 billion in 2023 and is poised to grow from USD 327.61 billion in 2024 to USD 469.47 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

The global keratometer market is dominated by major companies that are working on enhancing the specifications and features of automated keratometers as well as growing their product range through collaborations, partnerships, mergers, and acquisitions. For instance, in May 2021, by acquiring Capture 3D, ZEISS expanded its national footprint in the United States for its Industrial Quality & Research sector. 'Carl Zeiss Meditec AG (Germany) ', 'Topcon Corporation (Japan) ', 'NIDEK CO., LTD. (Japan) ', 'Haag-Streit Holding AG (Switzerland) ', 'Kowa Company, Ltd. (Japan) ', 'Righton Co., Ltd. (Japan) ', 'Shin-Nippon (Japan) ', 'MediWorks (China) ', 'Visionix (France) ', 'Canon Inc. (Japan) ', 'Huvitz Co., Ltd. (South Korea) ', 'Marco Ophthalmic (USA) ', 'CSO Costruzione Strumenti Oftalmici (Italy) ', 'Optopol Technology Sp. z o.o. (Poland) ', 'SBM Sistemi (Italy) ', 'Woodlyn Instruments (USA) ', '66 Vision Tech Co., Ltd. (China) ', 'Eye Care Products (India)'

The global keratometer market is primarily driven by technical advances, government initiatives to improve health services, and the widespread use of ophthalmic equipment for various healthcare procedures. The rising acceptance rate for prescription lenses and glasses is another factor driving the global keratometer market.

To meet this expanding demand, leading manufacturers in the market are developing new products with unique characteristics such as glare testing and auto-refractors. The company is introducing a new automated keratometer that includes a refractometer, a 7.0-inch touchscreen display, and mild voice guiding. In the near future, a plethora of such developments is expected to promote growth.

In 2021 North America had the biggest market share, owing to factors such as rising astigmatism incidence, increased awareness about ophthalmic care, rising health care expenditure, an older population, a well-established medical service, and a higher demand for preventive medical care such as ophthalmic assessment.